Kim Tae-Hee, Vemuganti Raghu
Department of Neurological Surgery, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA; Neuroscience Training Program, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.
CNS Neurosci Ther. 2015 Apr;21(4):327-36. doi: 10.1111/cns.12346. Epub 2014 Nov 18.
Stroke is one of the leading causes of death and disability worldwide. Experimental and clinical studies showed that sex and age play an important role in deciding the outcome after stroke. At younger ages, males were shown to have a higher risk for stroke than females. However, this trend reverses in older ages particularly when females reach menopause. Many preclinical studies indicate that steroid hormones modulate the age-dependent differential stroke outcome. In addition, patterns of cell death pathways activated following cerebral ischemia are distinct between males and females, but independent of steroid hormones. Recent studies also indicate that microRNAs play important roles in mediating sex-specific stroke outcome by regulating stroke-related genes. This review discusses the contribution of sex and age to outcome after stroke with particular emphasis on the experimental studies that examined the effects of steroid hormones, differential cell death pathways, and involvement of sex-specific microRNAs following cerebral ischemia. Current understanding of the role of thrombolytic agents in stroke therapy is also discussed.
中风是全球范围内主要的死亡和致残原因之一。实验和临床研究表明,性别和年龄在决定中风后的预后方面起着重要作用。在较年轻的年龄段,男性中风风险高于女性。然而,这种趋势在老年时会逆转,尤其是女性进入更年期后。许多临床前研究表明,类固醇激素调节年龄依赖性的中风预后差异。此外,脑缺血后激活的细胞死亡途径模式在男性和女性之间是不同的,但与类固醇激素无关。最近的研究还表明,微小RNA通过调节中风相关基因在介导性别特异性中风预后方面发挥重要作用。本综述讨论了性别和年龄对中风后预后的影响,特别强调了研究类固醇激素的作用、不同细胞死亡途径以及脑缺血后性别特异性微小RNA参与情况的实验研究。还讨论了目前对溶栓药物在中风治疗中作用的理解。